About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 2/3NCT05103644

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

Statins, a major class of drugs for treatment of hypercholesterolemia, are widely used due to a notable prevention of cardiovascular disease, and accumulating evidence proposes a promising role of sta...

Lead sponsor: Beni-Suef University•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

ALshaimaa Ibrahim Rabie, Msc

CONTACT

01061263030 alshaimaa.ph@o6u.edu.eg

Raghda RS Hussein, PHD

CONTACT

Raghda.hussien@phram.bsu.edu.eg

Sponsors

Lead Sponsor

Beni-Suef University

Statin has lipid independent effects include inhibition of inflammatory responses, immunomodulatory actions, apoptotic and antiproliferative effects, which might contribute to the suggested anti-tumoral effects of these agents. The epidemiological evidence projecting statins as anticancer agents is variable, depending on the particular type of cancer in question as well as the class of statin used

Age

18 - 80 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•1. Confirmed breast cancer any stage confirmed by radiological and pathological or by clinical evaluation undergo surgery or receiving neo/adjuvant chemotherapy treatment
•2. Age above 18 years
•3. HER2 negative core biopsy
•4. Adequate renal function: the calculated creatinine clearance should be ≥50 mL/min
•5. Patients must be accessible for treatment and follow-up
•6. Performance status of Eastern Cooperative Oncology Group (ECOG) ≤ 2

Exclusion Criteria

•1. Known hypersensitivity reaction to the investigational compounds or incorporated substances
•2. patients who are unlikely to comply with trial requirements (eg, confusion, psychological or mood disturbances ,alcoholism, cardiac arrhythmia)

Related studies

RECRUITINGPhase 1

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

NCT06347068 · Breast Cancer, Relapse, and more

RECRUITINGPhase 3

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

NCT06500481 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship

NCT07655934 · Breast Cancer

MRg-NIRS Imaging System Breast Cancer Trial

NCT06400563 · Breast Cancer

RECRUITINGPhase 1/2

A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

NCT06188520 · ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 2, 2022Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2/PHASE3

Enrollment60

Start dateOct 2021

Last updatedNov 2, 2022

Condition

Locations shown

Fayoum Oncology Center

Al Fayyum

Beni-Suef university hospital

Banī Suwayf

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 2, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions